Drug Giant Is Fined $1.2 Billion in Risperdal Case
Thursday, April 12, 2012 - 01:30
in Psychology & Sociology
A judge fined Johnson & Johnson and a subsidiary after a jury found that the companies minimized or concealed the dangers associated with Risperdal, an antipsychotic drug.